unknown
Stage
About
InGel Therapeutics develops engineered cell therapies using precursor retinal neurons combined with a biomimetic hydrogel platform to treat complex retinal degenerative diseases such as retinitis pigmentosa, dry AMD, and glaucoma.
Explore InGel Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.